Monitor the special meeting outcome on August 28, 2026. If approved, watch for the board's decision on the split ratio and effective date. The reverse split does not alter business fundamentals but could reduce liquidity and create odd-lot holdings. The up-listing attempt remains contingent on regulatory changes regarding cannabis.
Price Chart
Executive Summary
Ascend Wellness Holdings filed a preliminary proxy statement to convene a special meeting on August 28, 2026, seeking stockholder approval for a reverse stock split of its Class A common shares at a ratio between 1-for-10 and 1-for-50, with the board retaining discretion over the final ratio and implementation. The split is intended to increase the share price to meet the minimum bid price requirement for a potential up-listing to NYSE American or Nasdaq. The board unanimously recommends voting 'FOR' the proposal, along with an adjournment proposal to solicit additional proxies if needed.
Key Facts
- Special meeting scheduled for August 28, 2026 to vote on reverse stock split and adjournment.
- Reverse stock split ratio range: 1-for-10 to 1-for-50, with board discretion on final ratio and implementation.
- Board unanimously recommends voting FOR both proposals.
- Record date: July 7, 2026; 203,029,462 Class A common shares outstanding.
- Purpose: to increase share price to meet minimum bid price requirement for potential NYSE American or Nasdaq listing.
- No fractional shares will be issued; fractional shares will be rounded up to the nearest whole share.
- Adult-use cannabis remains illegal under U.S. federal law, which may impede listing even after the reverse split.
Financial Impact
No direct financial impact from the proxy filing itself. If implemented, the reverse split will reduce the number of outstanding shares proportionally but will not change authorized shares or par value. Per-share net income/loss will be adjusted retrospectively.
Risk Factors
- The reverse split may not increase the share price sufficiently to meet the minimum bid price requirement.
- Federal illegality of adult-use cannabis may prevent listing on a national exchange even after the split.
- Post-split price declines could lead to reduced liquidity and increased volatility.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| PREM14A Filing (Primary) | 0001104659-26-077794 |
| Document: 0001104659-26-077794-index-headers.html | 0001104659-26-077794 |
| Document: 0001104659-26-077794-index.html | 0001104659-26-077794 |
| Document: 0001104659-26-077794.txt | 0001104659-26-077794 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 10, 2026 11w ago | DEFA14A | $0.4000 $0.4795 | ▲ +19.88% | ▲ +20.93% | $0.3960 (−1.00%) |
Jun 25, 2026 17w ago | PREM14A | $0.4680 $0.4000 | ▼ −14.53% | ▼ −15.89% | $0.3960 (−15.38%) |
Mar 26, 2026 30w ago | Court Ruling | $0.4440 $0.5900 | ▲ +32.88% | ▲ +20.10% | $0.3960 (−10.81%) |
Mar 20, 2026 31w ago | DEFA14A | $0.5070 $0.4710 | ▼ −7.10% | ▼ −14.52% | $0.3960 (−21.89%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers